Similar Posts
Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs
Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs Thu, 18 Nov 2004 The Associated Press reports that at a Congressional hearing today, Dr. David Graham a drug safety expert at the FDA told the Senate Finance Committee that the public is “virtually defenseless” if another medication such as Vioxx…
Scientific Misconduct Notices
Scientific Misconduct Notices News Stories on Human Research Protection and Commentary by Vera Hassner Sharav April 22, 2002 Scientific misconduct is a big problem undermining the integrity of the scientific literature. Data falsification leads others to erroneous conclusions that may have adverse consequences for patients in clinical research and clinical…
Go Slow on Mental Health Screening: Dr. Effrem Responds to New Freedom Commission Chair
Go Slow on Mental Health Screening: Dr. Karen Effrem responds to New Freedom Commission Chair, Michael Hogan – Wash Times Sun, 31 Oct 2004 A letter to the editor in the Washington Times – Go slow on Mental Health Screening – by AHRP’s newest board member, pediatrician Dr. Karen Effrem,…
AHRP Comments – Precursors to Diabetes in Japanese American Youth
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) August 21, 2002 Comments Re: DHHS Notice of Proposed Recommendation Regarding Support of Research Protocol: "Precursors to Diabetes in Japanese American Youth" Grant Number I R01 DK59234-01 The proposed experiment would involve 450 children healthy children, aged 8-10 years old, 300 of Japanese ancestry…
War hero’s death in clinical trial follows years of FDA neglect – Bloomberg News
War hero’s death in clinical trial follows years of FDA neglect – Bloomberg News Thu, 10 Nov 2005 Bloomberg News reports that a decorated veteran of the Vietnam war was killed in 2002, in a clinical drug trial at the FABRE Research Clinic in Houston, Texas. The FDA had found…
$1.1 Billion in Stimulus Package for Comparing Medical Treatments
This has the potential for restoring integrity to medicine by providing doctors and the public with impartial risk / benefit information about existing treatments devoid of commercial bias.

